Cargando…
Novel treatment for gastric intestinal metaplasia, a precursor to cancer
BACKGROUND AND AIM: Gastric intestinal metaplasia (GIM) is precancerous with a worldwide prevalence of 25%. Eradicating Helicobacter pylori prevented about half of gastric cancers; failure to prevent the rest was attributed to GIM. GIM is irreversible and often extensive. There is no treatment. Exis...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411557/ https://www.ncbi.nlm.nih.gov/pubmed/32782940 http://dx.doi.org/10.1002/jgh3.12318 |